Nancy J. Hutson, Director at Clearside Biomedical, Inc. (CLSD), bought 30,000 shares at $1.33 ($40K) on 2022-11-17, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| BCRX | SELL | 2021-10-19 | $1.6M | — | Filing → |